BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 21909982)

  • 21. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
    Maor S; Mayer D; Yarden RI; Lee AV; Sarfstein R; Werner H; Papa MZ
    J Endocrinol; 2006 Dec; 191(3):605-12. PubMed ID: 17170218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition.
    Yang X; Ferguson AT; Nass SJ; Phillips DL; Butash KA; Wang SM; Herman JG; Davidson NE
    Cancer Res; 2000 Dec; 60(24):6890-4. PubMed ID: 11156387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer.
    Cappelletti V; Gariboldi M; De Cecco L; Toffanin S; Reid JF; Lusa L; Bajetta E; Celio L; Greco M; Fabbri A; Pierotti MA; Daidone MG
    Endocr Relat Cancer; 2008 Jun; 15(2):439-49. PubMed ID: 18508997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective evaluation of estrogen receptor-beta in predicting response to neoadjuvant antiestrogen therapy in elderly breast cancer patients.
    Cappelletti V; Celio L; Bajetta E; Allevi A; Longarini R; Miodini P; Villa R; Fabbri A; Mariani L; Giovanazzi R; Galante E; Greco M; Grazia Daidone M
    Endocr Relat Cancer; 2004 Dec; 11(4):761-70. PubMed ID: 15613450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 17β-estradiol enhances α(5) integrin subunit gene expression through ERα-Sp1 interaction and reduces cell motility and invasion of ERα-positive breast cancer cells.
    Sisci D; Middea E; Morelli C; Lanzino M; Aquila S; Rizza P; Catalano S; Casaburi I; Maggiolini M; Andò S
    Breast Cancer Res Treat; 2010 Nov; 124(1):63-77. PubMed ID: 20052536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells.
    Gionet N; Jansson D; Mader S; Pratt MA
    J Cell Biochem; 2009 Jun; 107(3):448-59. PubMed ID: 19350539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of 14-3-3β in transcriptional activation of estrogen receptor α and its involvement in proliferation of breast cancer cells.
    Kim Y; Kim H; Jang SW; Ko J
    Biochem Biophys Res Commun; 2011 Oct; 414(1):199-204. PubMed ID: 21946067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen receptor expression and sensitivity to paclitaxel in breast cancer.
    Dougherty MK; Schumaker LM; Jordan VC; Welshons WV; Curran EM; Ellis MJ; El-Ashry D
    Cancer Biol Ther; 2004 May; 3(5):460-7. PubMed ID: 15020841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroglobin overexpression induced by the 17β-Estradiol-Estrogen receptor-α Pathway reduces the sensitivity of MCF-7 Breast cancer cell to paclitaxel.
    Fiocchetti M; Cipolletti M; Leone S; Ascenzi P; Marino M
    IUBMB Life; 2016 Aug; 68(8):645-51. PubMed ID: 27312786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarker analysis of neoadjuvant doxorubicin/cyclophosphamide followed by ixabepilone or Paclitaxel in early-stage breast cancer.
    Horak CE; Pusztai L; Xing G; Trifan OC; Saura C; Tseng LM; Chan S; Welcher R; Liu D
    Clin Cancer Res; 2013 Mar; 19(6):1587-95. PubMed ID: 23340299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ERα directly activated the MDR1 transcription to increase paclitaxel-resistance of ERα-positive breast cancer cells in vitro and in vivo.
    Shi JF; Yang N; Ding HJ; Zhang JX; Hu ML; Leng Y; Han X; Sun YJ
    Int J Biochem Cell Biol; 2014 Aug; 53():35-45. PubMed ID: 24786296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression profiling of breast tumor cell lines to predict for therapeutic response to microtubule-stabilizing agents.
    Kadra G; Finetti P; Toiron Y; Viens P; Birnbaum D; Borg JP; Bertucci F; Gonçalves A
    Breast Cancer Res Treat; 2012 Apr; 132(3):1035-47. PubMed ID: 21792624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ERα positively regulated DNMT1 expression by binding to the gene promoter region in human breast cancer MCF-7 cells.
    Shi JF; Li XJ; Si XX; Li AD; Ding HJ; Han X; Sun YJ
    Biochem Biophys Res Commun; 2012 Oct; 427(1):47-53. PubMed ID: 22975348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
    Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
    Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isobavachalcone sensitizes cells to E2-induced paclitaxel resistance by down-regulating CD44 expression in ER+ breast cancer cells.
    Shi J; Chen Y; Chen W; Tang C; Zhang H; Chen Y; Yang X; Xu Z; Wei J; Chen J
    J Cell Mol Med; 2018 Nov; 22(11):5220-5230. PubMed ID: 30179299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER
    Formisano L; Stauffer KM; Young CD; Bhola NE; Guerrero-Zotano AL; Jansen VM; Estrada MM; Hutchinson KE; Giltnane JM; Schwarz LJ; Lu Y; Balko JM; Deas O; Cairo S; Judde JG; Mayer IA; Sanders M; Dugger TC; Bianco R; Stricker T; Arteaga CL
    Clin Cancer Res; 2017 Oct; 23(20):6138-6150. PubMed ID: 28751448
    [No Abstract]   [Full Text] [Related]  

  • 37. Endocrine resistant breast cancer cells with loss of ERα expression retain proliferative ability by reducing caspase7-mediated HDAC3 cleavage.
    Yu S; Gong X; Ma Z; Zhang M; Huang L; Zhang J; Zhao S; Zhu T; Yu Z; Chen L
    Cell Oncol (Dordr); 2020 Feb; 43(1):65-80. PubMed ID: 31701491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxamic acid analogue histone deacetylase inhibitors attenuate estrogen receptor-alpha levels and transcriptional activity: a result of hyperacetylation and inhibition of chaperone function of heat shock protein 90.
    Fiskus W; Ren Y; Mohapatra A; Bali P; Mandawat A; Rao R; Herger B; Yang Y; Atadja P; Wu J; Bhalla K
    Clin Cancer Res; 2007 Aug; 13(16):4882-90. PubMed ID: 17699868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The synergistic combination of the farnesyl transferase inhibitor lonafarnib and paclitaxel enhances tubulin acetylation and requires a functional tubulin deacetylase.
    Marcus AI; Zhou J; O'Brate A; Hamel E; Wong J; Nivens M; El-Naggar A; Yao TP; Khuri FR; Giannakakou P
    Cancer Res; 2005 May; 65(9):3883-93. PubMed ID: 15867388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen response element-GFP (ERE-GFP) introduced MCF-7 cells demonstrated the coexistence of multiple estrogen-deprivation resistant mechanisms.
    Fujiki N; Konno H; Kaneko Y; Gohno T; Hanamura T; Imami K; Ishihama Y; Nakanishi K; Niwa T; Seino Y; Yamaguchi Y; Hayashi S
    J Steroid Biochem Mol Biol; 2014 Jan; 139():61-72. PubMed ID: 24128438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.